Frontotemporal clear cell meningioma. Report of 3 cases

Annals of Diagnostic Pathology

Volumn 11, Issue 3, 2007, Pages 182-189

  Tena Suck, Martha Lilia ^a   Salinas Lara, Citlaltepelt ^a   Gómez, Celedonio ^b   Bojórquez, Daniel Rembao ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Brain tumors; Clear cell meningioma; Immunohistochemistry

Indexed keywords

COLLAGEN FIBRIL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; EPITHELIAL MEMBRANE ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BLOOD VESSEL; CARDIOMYOPATHY; CASE REPORT; CELL NUCLEUS; CLEAR CELL MENINGIOMA; COLLAGEN DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; CYTOPLASM; FEMALE; FRONTAL LOBE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEIOMYOMATOSIS; MENINGIOMA; POSTMENOPAUSE; PRIORITY JOURNAL; SUBDURAL HEMATOMA; TEMPORAL LOBE;

CA-15-3 ANTIGEN; CELL ADHESION MOLECULES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRONTAL LOBE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RECEPTORS, PROGESTERONE; TEMPORAL LOBE; TOMOGRAPHY, X-RAY COMPUTED; VIMENTIN;

EID: 34247842983     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2006.03.007     Document Type: Article

References (35)

1. Louis D.N., Scheithauer B.W., Budka H., von Deimling A., and Kepes J.J. In: Keihues P., and Cavenee W.K. (Eds). Tumors of the nervous system, pathology and genetics. World Health Organization classification of tumors (2000), IARC Press Lyon 244-246
2. Kuzeyli K., Cakir E., Usul H., Karaarslan G., Kadir Reis A., Temiz C., et al. Clear cell meningioma: case report and literature review. J Clin Neurosci 10 (2003) 264-266
3. Jallo G.L., Kthbauer K.F., Silverira M., and Epstien F.J. Intraspinal clear cell meningiomas: diagnosis and management; report of two cases. Neurosurgery 48 (2001) 218-222
4. Yu K.B., Lim M.K., Kim H.J., Suh C.H., Park H.C., Kim E.Y., et al. Clear-cell meningioma: CT and MR imaging findings in two cases involving the spinal canal and cerebellopontine angle. Korean J Radiol 3 (2002) 125-129
5. Liu P.I., Liu G.C., Tsai K.B., Lin C.L., and Hsu J.S. Intraspinal clear cell meningiomas; a case report and review of the literature. Surg Neurol 3 (2005) 285-289
6. Boet R., Ng H.K., Kumta S., Chan L.C., Chiu K.W., and Poon W.S. Lumbosacral clear-cell meningiomas treated with subtotal resection and radiotherapy. J Clin Neurosci 11 (2004) 432-436
7. Zorludemir S., Scheithauer B.W., and Hirose T. Clear cells meningiomas; a clinicopathologic study of potentially aggressive variant of meningiomas. Am J Surg pathol 19 (1995) 493-505
8. Pimentel J., Fernandez A., Pinto A.E., Fonseca I., Moura Núñez J.F., and Lobo Antunez J. Clear cells meningioma variant and clinical aggressiveness. Clin Neuropathol 17 (1998) 141-146
9. Pinz M., Patts S., Mitrovics T., and Vervos-Navarro J. Clear cell meningioma; report of spinal case. Gen diagn Pathol 141 (1996) 261-269
10. Manivel J.C., and Sung J.M. Pathology of meningiomas. Pathol Annu 2 (1990) 159-192
11. Jellinger K., and Slowitk F. Histological subtypes and prognostic problems in meningioma. J Neurol 208 (1975) 279-298
12. Wahab M., and Al-Azzawi F. Meningioma and hormonal influences. Climacteric 6 (2003) 285-292
13. Taddei G.L., Caldarella A., Raspollini M.R., Taddei A., and Buccoliero A.M. Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations. Pathologica 94 (2002) 10-15
14. Blankenstein M.A., Verheijen F.M., Jacobs J.M., Donker T.H., van Duijnhoven M.W., and Thijssen J.H. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 65 (2000) 795-800
15. Went P.T., Lugli A., Meier S., Bundi M., Mirlacher M., Sauter G., et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 35 (2004) 122-128
16. Osta W.A., Chen Ym Mikhitarian K., Mitras M., Salen M., Hannun Y.A., Cole D.J., et al. EpCAM is overexpressed in breast cancer and it is a potential target for breast cancer Gene therapy. Cancer Res 64 (2004) 5818-5824
17. Das A., Tan W.L., and Smith D.R. Expression of the inhibitor of apoptosis protein survivin in benign meningiomas. Cancer Lett 193 (2003) 217-223
18. Shono T., Inamura T., Torisu M., Suzuki S.O., and Fukui M. Vascular endothelial growth factor and malignant transformation of a meningioma: case report. Neurol Res 22 (2000) 189-193
19. Kuratsu J.l., Seto H., Kochi M., and Ushio Y. Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma. Acta Neurochir (Wien) 131 (1994) 289-293
20. Lin C.C., Kenyon L., Hyslop T., Hammond E., Andrews D.W., Curran Jr. W.J., et al. Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade. Am J Clin Oncol 26 (2003) 98-102
21. Forseen S.E., Potti A., Koka V., Koch M., Fraiman G., and Levitt R. Identification and relationship of HER-2/neu overexpression to short-term mortality in primary malignant brain tumors. Anticancer Res 22 (2002) 1599-1602
22. Potti A., Panwalkar A., Langness E., Sholes K., Tendulkar K., Chittajalu S., et al. Role of Her-2/neu overexpression and clinical features at presentation as predictive factors in meningiomas. Am J Clin Oncol 27 (2004) 452-466
23. Hakin-Smith V., Battersby R.D., Maltby E.L., Timperley W.R., and Royds J.A. Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence. Neuropathol Appl Neurobiol 27 (2001) 40-49
24. Honda M., Bara S., Kaminogo M., Tamaru N., and Nagata I. Rapidly growing microcystic meningioma of the middle fossa floor. Neurol med Chir (Tokyo) 45 (2005) 311-314
25. Fouladi M., Helton K., Dalton J., Gilger E., Gajjar A., Merchant T., et al. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients. Cancer 98 (2003) 2232-2244
26. Koperek O., Gelpi E., Birner P., Haberler C., Budka H., and Hainfellner J.A. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors. Acta Neuropathol (Berl) 108 (2004) 24-30
27. Cimatti M., Salvati M., Caroli E., Frati A., Brogna C., and Gagliardi F.M. Extremely delayed cerebral metastasis from renal carcinoma: report of four cases and critical analysis of the literature. Tumori 90 (2004) 342-344
28. Klos K.J., and O'Neill B.P. Brain metastases. Neurologist 10 (2004) 31-46
29. Koperek O., Gelpi E., Birner P., Haberler C., Budka H., and Hainfellner J.A. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors. Acta Neuropathol (Berl) 108 (2004) 24-30
30. Sell M., Sampaolo S., Di Lorio G., and Theallier A. Chordomas: a histological and immunohistochemical study of cases with and without recurrent tumors. Clin Neuropathol 23 (2004) 277-285
31. Houdouin L., Polivka M., Henegar C., Blanquet A., Delalande O., and Mikol J. Pituitary germinoma and lymphocytic hypophysitis: a pitfall. Report of two cases. Ann Pathol 23 (2003) 349-354
32. Dundar E., Arslantas A., Acikalin M.F., and Tel E. Cerebellar metastasis from clear cell sarcoma of the kidney. A case report with immunohistochemistry. J Neurosurg Sci 45 (2001) 228-231
33. Korshunov A., and Golanov A. Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single institute. J Neurooncol 5 (2001) 63-72
34. Withers T., Klevansky A., and Weinstein S.R. Lipomeningiomas: case report and review of the literature. J Clin Neurosci 10 (2003) 712-714
35. Ohnisti T., and Watanabe S. Histogenesis of clear cell hidradenoma; immunohistochemical study of keratin expression. J Cutan Pathol 24 (1997) 30-36